Literature DB >> 18806631

Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: results of the I-inSYST survey.

Patricia Van der Niepen1, Christophe Giot, Philippe van de Borne.   

Abstract

OBJECTIVE: To evaluate the prevalence of isolated uncontrolled systolic blood pressure (on-treatment isolated systolic hypertension) in treated hypertensive patients and identify the characteristics and treatment strategy in these patients.
METHODS: Prospective cross-sectional survey in primary care. Participating physicians enrolled more than 13 consecutive treated hypertensive patients. Patients were considered to have isolated systolic hypertension when systolic blood pressure was at least 140 mmHg and diastolic blood pressure was less than 90 mmHg.
RESULTS: On-treatment isolated systolic hypertension occurred in 28% of evaluable patients (n = 11562) and in 36% of uncontrolled patients (n = 9080). Among the isolated systolic hypertension and among other uncontrolled patients, 53% and 47%, respectively, used more than one antihypertensive drug class. beta-Blockers were the most frequently prescribed antihypertensive drugs. Patients with isolated uncontrolled systolic blood pressure were more frequently treated with diuretics (43 vs. 39%) and angiotensin II receptor antagonists (23 vs. 17%). Despite blood pressure being under control in only 21% of the patients, hypertension treatment was not changed in 46% of patients with isolated uncontrolled systolic blood presssure vs. 14% of patients with both uncontrolled systolic and diastolic blood pressure.
CONCLUSION: In Belgium, the prevalence of on-treatment isolated systolic hypertension in treated hypertensive patients, was 28%. The goal blood pressure was likely not reached in most patients due to inadequate treatment. The overall control rate was worse for systolic than for diastolic blood pressure. Furthermore, antihypertensive treatment was less frequently adapted in patients with isolated uncontrolled systolic blood pressure than in those patients with both uncontrolled systolic and diastolic blood pressure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806631     DOI: 10.1097/HJH.0b013e32830a9a49

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Improved blood pressure control in elderly hypertensive patients: results of the PAPY-65 Survey.

Authors:  Patricia Van der Niepen; Alain G Dupont
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

2.  "Later, lazier, and unluckier": a heuristic profile of high vulnerability is an independent predictor of uncontrolled blood pressure (the PREVIEW study).

Authors:  Ivo Abraham; Christopher Lee; Minkyoung Song; Stefaan Vancayzeele; Heidi Brié; Christine Hermans; Patricia Van der Niepen; Karen Macdonald
Journal:  Int J Gen Med       Date:  2010-07-21

Review 3.  Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection.

Authors:  Bernard Waeber; François Feihl; Luis M Ruilope
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 4.  Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program.

Authors:  Ivo Abraham; Karen MacDonald; Christine Hermans; Ann Aerts; Christopher Lee; Heidi Brié; Stefaan Vancayzeele
Journal:  Vasc Health Risk Manag       Date:  2011-03-31

5.  Assessment of Prevalence, Awareness, and Characteristics of Isolated Systolic Hypertension Among Younger and Middle-Aged Adults in China.

Authors:  Shiwani Mahajan; Fang Feng; Shuang Hu; Yuan Lu; Aakriti Gupta; Karthik Murugiah; Yan Gao; Jiapeng Lu; Jiamin Liu; Xin Zheng; Erica S Spatz; Haibo Zhang; Harlan M Krumholz; Jing Li
Journal:  JAMA Netw Open       Date:  2020-12-01

6.  Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patients.

Authors:  Ivo Abraham; Yoleen Van Camp; Lorenzo Villa; Kris Denhaerynck; Diana Sun; Stefaan Vancayzeele; Heidi Brié; Ann Aerts; Christine Hermans; Karen MacDonald
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-12       Impact factor: 3.738

7.  Cross-sectional survey evaluating blood pressure control ACHIEVEment in hypertensive patients treated with multiple anti-hypertensive agents in Belgium and Luxembourg.

Authors:  Marc Leeman; Michèle Dramaix; Bregt Van Nieuwenhuyse; Josse R Thomas
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.